- Home
- INMB vs MLSS Comparison
INMB vs MLSS Comparison
Compare INMB & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- MLSS
- Stock Information
- Founded
- INMB 2015
- MLSS 1989
- Country
- INMB United States
- MLSS United States
- Employees
- INMB N/A
- MLSS N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- MLSS Industrial Specialties
- Sector
- INMB Health Care
- MLSS Health Care
- Exchange
- INMB Nasdaq
- MLSS Nasdaq
- Market Cap
- INMB 49.2M
- MLSS 42.4M
- IPO Year
- INMB 2019
- MLSS 1995
- Fundamental
- Price
- INMB $1.83
- MLSS $0.42
- Analyst Decision
- INMB Hold
- MLSS Buy
- Analyst Count
- INMB 3
- MLSS 1
- Target Price
- INMB $4.30
- MLSS $1.25
- AVG Volume (30 Days)
- INMB 361.9K
- MLSS 203.1K
- Earning Date
- INMB 10-30-2025
- MLSS 11-14-2025
- Dividend Yield
- INMB N/A
- MLSS N/A
- EPS Growth
- INMB N/A
- MLSS N/A
- EPS
- INMB N/A
- MLSS N/A
- Revenue
- INMB $50,000.00
- MLSS $9,083,205.00
- Revenue This Year
- INMB $264.29
- MLSS $16.06
- Revenue Next Year
- INMB $9,819.61
- MLSS $14.73
- P/E Ratio
- INMB N/A
- MLSS N/A
- Revenue Growth
- INMB 19.05
- MLSS 7.84
- 52 Week Low
- INMB $1.71
- MLSS $0.38
- 52 Week High
- INMB $11.64
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- INMB 44.66
- MLSS 38.88
- Support Level
- INMB $1.73
- MLSS $0.40
- Resistance Level
- INMB $1.89
- MLSS $0.48
- Average True Range (ATR)
- INMB 0.10
- MLSS 0.04
- MACD
- INMB 0.00
- MLSS 0.00
- Stochastic Oscillator
- INMB 37.04
- MLSS 12.67
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.